Cerebral Palsy Market Research Report Global Forecast to …

Market Scenario

The global cerebral palsy market is expected to grow significantly over the forecast period. Cerebral palsy (CP) refers to a group of neurological conditions that affect muscle movement and coordination. CP can be caused by damage that occurs to the immature developing brain of an infant. In addition to this, other possible causes of CP include asphyxia neonatorum, bleeding into the brain, brain infections, and severe jaundice in the infants. Cerebral palsy is the most common form of childhood disability. According to the Cerebral Palsy Guidance, around 10,000 babies are born each year in the US with cerebral palsy.

The global cerebral palsy market is driving owing to the growing prevalence of cerebral palsy coupled with increasing awareness about the condition. Moreover, the growing adoptions of medications for controlling the symptoms of the cerebral palsy are anticipated to propel the market growth. Additionally, increasing expenditure for the healthcare sector in developed economies and increasing insurance coverage contribute to the growth of the market.

Despite the drivers, side effects associated with medications and high treatment cost and lack of awareness in some developing regions may hamper the market growth during the assessment period.

Segmentation

The global cerebral palsy market has been segmented into type, diagnosis, and treatment.

The market, on the basis of type, has been segmented into spastic cerebral palsy, dyskinetic cerebral palsy, hypotonic cerebral palsy, ataxic cerebral palsy, and mixed cerebral palsy.

The market, by diagnosis, has been segmented into imaging tests and others. The imaging tests have been further segmented into magnetic resonance imaging (MRI), cranial ultrasound, computed tomography, and electroencephalogram.

The market, by treatment, has been segmented into therapy, medication, surgery, and others. The therapy segment has been segmented into nutrition therapy, hyperbaric oxygen therapy, occupational therapy, physical therapy, stem cell therapy, and others. The medication segment has been segmented into anti-convulsant drugs, muscle relaxants, anti-depressant drugs, anti-inflammatory drugs, and others. Further, the surgery segment has been segmented into orthopedic surgery and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The cerebral palsy market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European cerebral palsy market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The cerebral palsy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cerebral palsy market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Allergen Plc, Cellular Biomedicine Group, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline Plc, Abbott Laboratories, Acorda Therapeutics, Inc., Medtronic, Meridigen Biotech Co., Ltd., GW Pharmaceuticals Plc, and Cell Cure Neurosciences Ltd. are some of the key players in the global cerebral palsy market.

Regional Market Summary

Global Cerebral Palsy Market Share (%), by Region, 2017

Source: Centers for Disease Control and Prevention (CDC), White Papers, Company Presentations, Annual Reports

Geographically, the Americas is anticipated to dominate the global cerebral palsy market owing to a well-developed healthcare sector, rising prevalence of cerebral palsy and growing healthcare expenditure. Additionally, favorable reimbursement scenario in this region and a relatively large number of research and development (R&D) activities contributes to the growth of the market.

Europe is expected to hold the second largest position in the global cerebral palsy market. The market growth in this region is attributed to the growing prevalence of cerebral palsy, availability of funds for research, and increasing healthcare expenditure. According to the data stated by the National Institute for Health and Care Excellence (NICE) in 2017, in the UK, it is estimated that 1 in 400 babies are born with cerebral palsy. It also stated that approximately 1,800 children diagnosed with CP each year.

The cerebral palsy market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, rising prevalence of cerebral palsy and increasing government funding for the healthcare sector.

On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.

Global Cerebral Palsy Market, by Type

Global Cerebral Palsy Market, by Diagnosis

Global Cerebral Palsy Market, by Treatment

Global Cerebral Palsy Market, by Region

Intended Audience

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Cerebral Palsy Market, by Type

6.1 Introduction

6.2 Spastic Cerebral Palsy

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

6.3 Dyskinetic Cerebral Palsy

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

6.4 Hypotonic Cerebral Palsy

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

6.5 Ataxic Cerebral Palsy

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

6.6 Mixed Cerebral Palsy

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

Chapter 7. Global Cerebral Palsy Market, by Diagnosis

7.1 Introduction

7.2 Imaging Tests

7.2.1 Magnetic Resonance Imaging (MRI)

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

7.2.2 Cranial Ultrasound

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

7.2.3 Computerized Tomography (CT)

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

7.2.4 Electroencephalogram (EEG)

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

7.3 Others

Chapter 8. Global Cerebral Palsy Market, by Treatment

8.1 Introduction

8.2 Therapy

8.2.1 Nutrition Therapy

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

8.2.2 Hyperbaric Oxygen Therapy

Market Estimates & Forecast, by Region, 20182023

Market Estimates & Forecast, by Country, 20182023

8.2.3 Occupational Therapy

See the article here:
Cerebral Palsy Market Research Report Global Forecast to ...